Insights

Loading spinner
Gathering insights about Exo Therapeutics

Exo Therapeutics Tech Stack

Media & News

Exo Therapeutics's Email Address Formats

Exo Therapeutics uses at least 1 format(s):
Exo Therapeutics Email FormatsExamplePercentage
First.Last@exo-therapeutics.comJohn.Doe@exo-therapeutics.com
100%

Frequently Asked Questions

Where is Exo Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Exo Therapeutics's main headquarters is located at 150 Cambridge Park Drive, Suite 300. The company has employees across 2 continents, including North AmericaEurope.

What is Exo Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Exo Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Exo Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, Exo Therapeutics has approximately 18 employees across 2 continents, including North AmericaEurope. Key team members include President, Chief Operating Officer: D. L. B.Co-Founder & Employee 001: J. P. M.Executive Assistant To The President: H. C.. Explore Exo Therapeutics's employee directory with LeadIQ.

What industry does Exo Therapeutics belong to?

Minus sign iconPlus sign icon
Exo Therapeutics operates in the Biotechnology Research industry.

What is Exo Therapeutics's email format?

Minus sign iconPlus sign icon
Exo Therapeutics's email format typically follows the pattern of First.Last@exo-therapeutics.com. Find more Exo Therapeutics email formats with LeadIQ.

When was Exo Therapeutics founded?

Minus sign iconPlus sign icon
Exo Therapeutics was founded in 2018.

Exo Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company’s team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases.

Section iconCompany Overview

Headquarters
150 Cambridge Park Drive, Suite 300
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    Exo Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Exo Therapeutics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.